Mayo Clinic, Rochester, MN.
University of California San Diego, La Jolla, CA.
Chest. 2021 Nov;160(5):1808-1821. doi: 10.1016/j.chest.2021.05.074. Epub 2021 Jul 30.
The current national coverage determinations (NCDs) for noninvasive ventilation for patients with thoracic restrictive disorders, COPD, and hypoventilation syndromes were formulated in 1998. New original research, updated formal practice guidelines, and current consensus expert opinion have accrued that are in conflict with the existing NCDs. Some inconsistencies in the NCDs have been noted, and the diagnostic and therapeutic technology has also advanced in the last quarter century. Thus, these and related NCDs relevant to bilevel positive airway pressure for the treatment of OSA and central sleep apnea need to be updated to ensure the optimal health of patients with these disorders. To that end, the American College of Chest Physicians organized a multisociety (American Thoracic Society, American Academy of Sleep Medicine, and American Association for Respiratory Care) effort to engage experts in the field to: (1) identify current barriers to optimal care; (2) highlight compelling scientific evidence that would justify changes from current policies incorporating best evidence and practice; and (3) propose suggestions that would form the basis for a revised NCD in each of these 5 areas (thoracic restrictive disorders, COPD, hypoventilation syndromes, OSA, and central sleep apnea). The expert panel met during a 2-day virtual summit in October 2020 and subsequently crafted written documents designed to achieve provision of "the right device to the right patient at the right time." These documents have been endorsed by the participating societies following peer review and publication in CHEST and will be used to inform efforts to revise the current NCDs.
目前,针对患有胸壁限制性疾病、COPD 和通气不足综合征的患者的无创通气的全国覆盖范围决定(NCD)是在 1998 年制定的。新的原始研究、更新的正式实践指南和当前的共识专家意见与现有的 NCD 相冲突。NCD 中存在一些不一致之处,并且在过去的四分之一个世纪中,诊断和治疗技术也取得了进步。因此,这些以及与治疗 OSA 和中枢性睡眠呼吸暂停的双相气道正压通气相关的相关 NCD 需要更新,以确保这些疾病患者的最佳健康。为此,美国胸科学会组织了一个多学会(美国胸科学会、美国睡眠医学学会和美国呼吸治疗协会)的努力,让该领域的专家参与进来:(1)确定当前最佳护理的障碍;(2)强调有说服力的科学证据,这些证据将证明根据最佳证据和实践进行政策变更是合理的;(3)提出建议,为修订这五个领域(胸壁限制性疾病、COPD、通气不足综合征、OSA 和中枢性睡眠呼吸暂停)的每个 NCD 奠定基础。专家组于 2020 年 10 月在为期两天的虚拟峰会上举行了会议,并随后编写了旨在实现“在正确的时间为正确的患者提供正确的设备”的书面文件。这些文件在经过同行评议并发表在 CHEST 后,得到了参与协会的认可,并将用于为修订现行 NCD 提供信息。